#
Razadyne IR
  • Treatments
  • Alzheimer's Disease
  • Razadyne IR (Oral)

Razadyne IR (Oral)

Generic name:galantamine (oral route) [ ga-LAN-ta-meen ]
Drug class:Cholinesterase inhibitors

Medically reviewed by Drugs.com. Last updated on Feb 13, 2022.

Commonly used brand name(s)

In the U.S.

  • Razadyne
  • Razadyne ER
  • Razadyne IR

Available Dosage Forms:

  • Solution
  • Capsule, Extended Release
  • Tablet

Therapeutic Class: Central Nervous System Agent

Pharmacologic Class: Cholinesterase Inhibitor, Centrally/Peripherally Acting

Uses for Razadyne IR

Galantamine is used to treat mild to moderate dementia (memory loss and mental changes) that is a sign of Alzheimer's disease. Galantamine will not cure Alzheimer's disease, and it will not stop the disease from getting worse. However, galantamine can improve the thinking ability in some patients with Alzheimer's disease.

In Alzheimer's disease, many chemical changes take place in the brain. One of the earliest and biggest changes is that there is less of a chemical called acetylcholine (ACh). ACh helps the brain to work properly. Galantamine slows the breakdown of ACh, so it can build up and have a greater effect. However, as Alzheimer's disease gets worse, there will be less and less ACh, so galantamine may not work as well.

This medicine is available only with your doctor's prescription.

Before using Razadyne IR

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of galantamine in the pediatric population. Safety and efficacy h...